The Lipid Clinic Oslo University Hospital

Oslo 424

1 studies enrolling now · 4 studies all time

What they study most

Atherosclerosis, Cardiovascular Diseases, Familial Chylomicronemia Syndrome, Familial Hypercholesterolemia - Heterozygous, Hypertriglyceridemia, Severe Hypertriglyceridemia

Studies at this site

• Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH — Enrolling by invitation
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia — Completed
• CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
• A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS) — Completed